LN-144
CASE4622
Phase 1 mab terminated
Quick answer
LN-144 for Stage IIIB Melanoma is a Phase 1 program (mab) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Stage IIIB Melanoma
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated